We recommend
- Use of growth factors pre-emptively 24 hours after completion of
chemotherapy
- Shift of chemotherapy protocols as a day care outpatient therapy if
possible, without endangering patients with possible adverse effects
as nephrotoxicity.
- Delay all therapies beyond 1st line therapy unless
there is urgent clinical situation
- Delay imaging procedures to monitor response to treatment unless
urgent clinical condition